Drug Shortage Report for ZOFRAN
| Report ID | 75937 |
| Drug Identification Number | 02229639 |
| Brand name | ZOFRAN |
| Common or Proper name | ZOFRAN 4MG/5ML ORAL SOLN 50ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ONDANSETRON |
| Strength(s) | 4MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL |
| Packaging size | 50ML |
| ATC code | A04AA |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2019-02-25 |
| Actual start date | 2019-02-26 |
| Estimated end date | 2019-04-08 |
| Actual end date | 2019-04-08 |
| Shortage status | Resolved |
| Updated date | 2019-04-09 |
| Company comments | Demand increase due to generic backorder (ondansetron) |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.